Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H(HK:1276)
HK$49.92-0.33 (-0.66%)
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H ownership
HK$49.92
At close:-0.33 (-0.66%)
Want to see HK:1276 full AI Analyst Report?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Ownership - Who Owns Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H?
9 Followers
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Ownership Overview
- 18.01% Mutual Funds
- 4.13% ETFs
- 77.86% Public Companies and Individual Investors
The ownership structure of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) stock is a mix of institutional, retail, and individual investors. Approximately 22.14% of the company’s stock is owned by Institutional Investors, and 77.86% is owned by Public Companies and Individual Investors.
The ownership structure of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) stock is a mix of institutional, retail, and individual investors. Approximately 22.14% of the company’s stock is owned by Institutional Investors, and 77.86% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Specialized Funds | 9,939,973 | Institution | 3.85% | 63,248,048 |
| Eupac Fund | 8,358,600 | Institution | 3.24% | 53,185,772 |
| Vanguard | 7,759,900 | Institution | 3.01% | 49,376,244 |
| American Funds Global Insight Fund | 6,859,817 | Institution | 2.66% | 43,649,016 |
| New World Fund Inc | 4,080,800 | Institution | 1.58% | 25,966,130 |
| Vanguard International Equity Index Funds | 4,032,800 | Institution | 1.56% | 25,660,706 |
| Fidelity Investment Trust | 3,727,103 | Institution | 1.44% | 23,715,556 |
| Vanguard Star Funds | 3,186,400 | Institution | 1.23% | 20,275,063 |
| International Growth & Income Fund | 1,670,400 | Institution | 0.65% | 10,628,755 |
| Ishares | 1,610,600 | Institution | 0.62% | 10,248,248 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Specialized Funds | 9,939,973 | Institution | 3.85% | 63,248,048 |
| Eupac Fund | 8,358,600 | Institution | 3.24% | 53,185,772 |
| American Funds Global Insight Fund | 6,859,817 | Institution | 2.66% | 43,649,016 |
| New World Fund Inc | 4,080,800 | Institution | 1.58% | 25,966,130 |
| Vanguard International Equity Index Funds | 4,032,800 | Institution | 1.56% | 25,660,706 |
| Fidelity Investment Trust | 3,727,103 | Institution | 1.44% | 23,715,556 |
| Vanguard Star Funds | 3,186,400 | Institution | 1.23% | 20,275,063 |
| International Growth & Income Fund | 1,670,400 | Institution | 0.65% | 10,628,755 |
| American Funds International Vantage Fund | 1,236,800 | Institution | 0.48% | 7,869,758 |
| Goldman Sachs Trust | 832,800 | Institution | 0.32% | 5,299,106 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total International Stock ETF, VXUS ETF | 3,296,200 | Institution | 1.28% | 21,020,486 |
| Vanguard FTSE Emerging Markets ETF, VWO ETF | 3,259,800 | Institution | 1.26% | 20,788,356 |
| iShares China Large-Cap ETF, FXI ETF | 773,400 | Institution | 0.30% | 4,918,988 |
| Vanguard FTSE All-World ex-US Index Fund, VEU ETF | 568,200 | Institution | 0.22% | 3,623,515 |
| Schwab Emerging Markets Equity ETF, SCHE ETF | 261,066 | Institution | 0.10% | 1,672,209 |
| Roundhill GLP-1 & Weight Loss ETF, OZEM ETF | 256,800 | Institution | 0.10% | 1,644,884 |
| Vanguard Total World Stock ETF, VT ETF | 198,400 | Institution | 0.08% | 1,265,233 |
| iShares China Large Cap UCITS ETF AccumUSD, NL:FXAC ETF | 158,800 | Institution | 0.06% | 1,010,535 |
| Capital Group International Equity Select ETF, TSE:CAPI ETF | 127,200 | Institution | 0.05% | 1,158,152 |
| WisdomTree China ex-State-Owned Enterprises Fund, CXSE ETF | 115,200 | Institution | 0.04% | 737,892 |
FAQ
What percentage of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) stock is held by institutional investors?
According to the latest TipRanks data, approximately 22.14% of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) stock is held by institutional investors: 18.01% by mutual funds and 4.13% by ETFs.
What percentage of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) stock is held by retail investors?
According to the latest TipRanks data, approximately 77.86% of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) stock is held by public companies and individual investors.
Who owns the most shares of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)?
VANGUARD SPECIALIZED FUNDS owns the most shares of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
